NX Prenatal Inc. is a private molecular diagnostics company located in Louisville, KY, advancing women and children's health by providing innovative and novel methods to detect, monitor and manage pregnancy related complications. Their vision is to become a recognized leader in the advancement of women and children's health by providing innovative and novel methods to detect, monitor and manage pregnancy related complications. Its proprietary NeXosome,TM technology detects a new library of biomarkers for prenatal risk assessment as early as 10 weeks gestation. This technology has been shown through studies to provide physicians the opportunity to intervene in a timely manner with protocols for at-risk pregnancies to reduce the likelihood of a preterm birth or minimize the complications that can arise for child and mother.